Meng Xiangying, Zhao Rugang, Wu Shikai, Shen Ge, Ding Lijuan, Sun Bing, Wang Junliang
a Department of Radiation Oncology , Affiliated Hospital of Academy of Military Medical Sciences , Beijing , China.
b Radiotherapy Department , Navy General Hospital , Beijing , China.
Cancer Biol Ther. 2017 Jan 2;18(1):63-66. doi: 10.1080/15384047.2016.1276127.
A 40-year-old Chinese female patient, with radiation-induced brain necrosis after radiosurgery, was treated 6 times with a single dose of 200 mg (3.27 mg/kg) bevacizumab each time, and with an interval of 12-16 weeks between each treatment. Neurological symptoms such as dizziness, fatigue, and headache disappeared after each administration of bevacizumab. The results suggest that repeated bevacizumab treatment using a low-dose and long-dosing interval may significantly alleviate radiation necrosis and its symptoms.
一名40岁的中国女性患者,在接受放射外科手术后出现放射性脑坏死,每次接受单剂量200毫克(3.27毫克/千克)贝伐单抗治疗,共治疗6次,每次治疗间隔为12 - 16周。每次给予贝伐单抗后,头晕、乏力和头痛等神经症状均消失。结果表明,采用低剂量、长给药间隔的贝伐单抗重复治疗可能显著减轻放射性坏死及其症状。